Jennifer M. Sahni

EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion

Antonio Marzio, Emma Kurz, Jennifer M. Sahni et al. · Cell · 2021 · 120 citations · Full text

Medicine, Cancer Biology, Oncology +14

Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells

Sylvia S. Gayle, Jennifer M. Sahni, Bryan M. Webb et al. · Journal of Biological Chemistry · 2018 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +12

Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases

Jennifer M. Sahni, Sylvia S. Gayle, Kristen L. Weber-Bonk et al. · Journal of Biological Chemistry · 2016 · 56 citations · Full text

Medicine, Molecular Biology, Oncology +15

LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance

Melyssa S. Roberts, Jennifer M. Sahni, Morgan S. Schrock et al. · Cancer Research · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors

Jennifer M. Sahni, Sylvia S. Gayle, Bryan M. Webb et al. · Cancer Research · 2017 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17